Consequently, the full knowledge of the transduction crosstalk connecting several GPCR-dependent signals with other transduction pathways will promote further research regarding the biological potential of these receptors, meanwhile providing valuable avenues for the development of novel, GPCR-based therapeutic strategies for cancer diagnosis. Here, LPAR3 is linked to cancer.